First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis

EuroIntervention Journal

In preclinical studies, a bare metal cobalt-chromium stent with an active surface oxide layer modification (BMSmod) has been shown to inhibit neointimal hyperplasia effectively. In this prospective, non-randomised, first-in-man multicentre study, the authors sought to assess both the clinical safety and feasibility of the BMSmod.

Consult the article on EuroIntervention


Suwannasom P, Sotomi Y, Corti R, Kurz D, Roffi M, von Birgelen C, Buzzi S, Zucker A, Dijkstra J, Wykrzykowska J.J, de Winter R.J, Windecker S, Onuma Y, Serruys PW, Daemen J, Räber L


This case report does not reflect the opinion of PCR or PCRonline, nor does it engage their responsibility.